Each quarter Independence Blue Cross makes changes to its prescription drug formulary listing and procedures for safe prescribing.
Prior authorization requirements were placed on the following drugs when they entered the marketplace:
InvokanaTM Kazano® Kynamro®
Nesina® Oseni® Pomalyst®
Signifor® SirturoTM TecfideraTM
On October 1, 2013, we will add a prior authorization requirement to the following drugs for new prescriptions:
CystaranTM FulyzaqTM Procysbi® RavictiTM
Members taking these drugs prior to the effective date are not affected.
As part of the changes to the formulary effective October 1, 2013, ProAir HFA will be the only preferred brand of rescue inhaler for Select Drug Program formulary members. Medicare Part D members will not be affected by this change.
If members want to use a type of rescue inhaler other than ProAir HFA, they will need to obtain prior authorization and, in some cases, may be required to pay a higher level of cost-sharing.
On October 1, 2013, we will add a prior authorization requirement to the following drugs for all prescriptions:
Ready to make your benefit plan Superior? Contact Us
As your reliable partner, we can help you succeed by offering superior health and welfare services: Strategic Planning, Renewal Negotiation and Analysis, Compliance Support, and Effective Employee Communications.